Out of the 84 markers analyzed within the PEA Immune Oncology data set, a signature of nine proteins showed a statistical significant association to tumor stage (P < 0.05), including LAG3, IL12RB1, and CXCL10 (Fig. 3A, left panel). This evidence concerns the gene CXCL10 and neoplasm.